medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 02

<< Back Next >>

Ginecol Obstet Mex 2010; 78 (02)

Abnormal cervicovaginal cytology in women with rheumatoid arthritis

Mercado U
Full text How to cite this article

Language: Spanish
References: 11
Page: 94-98
PDF size: 319.71 Kb.


Key words:

Pap smear, squamous intraepithelial lesions, human papillomavirus.

ABSTRACT

Background: Patients with rheumatoid arthritis (RA) are at increased risk of infections and cancer. A link between RA and abnormal cervicovaginal cytology has rarely been reported.
Objective: The aim of this study was to review cervicovaginal cytology results in women with RA and compare them with a control population. Sexual behavior also was investigated.
Material and method: Cervicovaginal cytology results of 95 women with RA were compared to those of a control population of 1,719 women attending at the same hospital and followed until June 2009. Records of RA patients were reviewed to obtain clinical data, particularly sexual behavior.
Results: Of 95 RA patients, 13/95 had an abnormal cervicovaginal cytology result, compared with 120/1,719 controls. Twelve/13 had squamous intraepithelial lesions (SIL), compared with 27/120 controls. There was no significant difference in sexual partners between women with RA and controls. Women with RA without abnormal cervicovaginal cytology had less sexual partners than those with RA and abnormal cytology. Two women with RA and abnormal cervicovaginal cytology had a history of condylomata and herpes genital. Three/13 women with RA developed abnormal cervicovaginal cytology after 12 to 36 months initiating their illness. None from them had ever received immunosuppressants.
Conclusions: Women with RA have an increased prevalence of abnormal cervical cytology, compared with a control population. It may be related to chronic inflammatory disease and sexual behavior.


REFERENCES

  1. Mandic A, Vujkov T. Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann Oncol 2004;15:197-200.

  2. Dhar JP, Kmak D, Bhan R, et al. Abnormal cervicovaginal cytology in women with lupus: A retrospective cohort study. Gynecol Oncol 2001;82:4-6.

  3. Tam LS, Chan AY, Chan PK, et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 2004;50:3619-3625.

  4. Mercado U. Lesiones escamosas intraepiteliales en mujeres con lupus. Ginecol Obstet Mex (en prensa).

  5. Flores Alvarado DE, Ortiz López R, Garza Elizondo MA y col. Infection por VPH en mujeres con arthritis reumatoide. Medicina Universitaria 2008;10:205-211.

  6. Rojo Contreras W, Montoya Fuentes H, Gamez Nava JI y col. Prevalencia y factores asociados con infección por virus del papiloma humano cervical en pacientes con artritis reumatoide. Ginecol Obstet Mex 2008; 76:9-17.

  7. Weyand CM, Goronzy JJ, Kurtin PJ. Lymphoma in rheumatoid arthritis: an immune system set up for failure. Arthritis Rheum 2006;54:685-689.

  8. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006; 54:692-701.

  9. Chakravarty EF, Genovese MC. Associations between rheumatoid arthritis and malignancy. Rheum Dis Clin North Am 2004;30:271-284.

  10. Smitten AL, Simon TA, Hochberg MC, et al. A meta-analysis of the incidence of malignancy an adult patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:R45-52.

  11. Hudson M, Suissa S. Perspective on the risks of infection and malignancy with rheumatoid arthritis therapy. Future Rheumatology 2008;3:445-449.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2010;78